During the first admission she was started on vancomycin and discarged on this medication; however, when she was admitted on [**2155-7-14**], her vanc level was 51.6 and this antibiotic was discontinued.
She had blood and urine cultures sent.
A FAST ultrasound revealed complete collapse of IVC consistent with hypovolemic shock.
A CXR showed "mediastinal contours are similar in appearance with a bulging appearance, compatible with known lymphadenopathy.
A CT chest was done and is still pending.
Upon arrial to 11R vitals are: 97.2, 98/60, 95, 18, 95% on 2L.
Tumor involved left ovary and tube as serosal and surface adhesions, with no parenchymal involvement.
[**5-18**] CT torso: Stable pulm nodules, none new.
[**2153-9-3**] CT Torso: No evidence of residual tumor within the peritoneal cavity.
CA 125=7 [**2153-11-5**] Cycle #6 given without Avastin due to HTN, epistaxis.
[**2153-12-11**] Avastin as monotherapy for maintenance - last dose [**2154-4-3**] [**2154-3-29**] CT Torso: (CA 125 rising) Mild thickening and narrowing of the distal ileum which is likely due to contraction.
Otherwise, the study is essentially unchanged since previous examination.
Multiple other lymph nodes in the prevascular and presternal region are less than 10 mm in short axis.
Abdomen/pelvis: Extensive peritoneal, mesenteric, and omental metastases.
The study and the report were reviewed by the staff radiologist.
[**2154-8-23**] Abd ultrasound showed ascites not extensive, too little to tap.
[**2154-8-27**] Cardiac echo done for dyspnea.
[**Date range (1) 102268**] Weekly taxol, 60 mg/m2 (120 mg) x 3 cycles.
[**2154-11-1**] CT Torso: 1.
Cultures negative [**2155-4-11**] Cycle #1 Cytoxan and Doxil [**2155-4-14**] underwent paracentesis at the [**Hospital1 18**] with removal of 5.3 liters of ascites [**2155-4-23**] Seen at [**Hospital1 18**] for blood transfusion and orthostatic.
Urine cx with Kleb pneumonie.
[**2155-6-4**] Given #1 Topotecan at dose reduction to 2mg/m2 [**2155-6-12**] Pancytopenic, chemo held [**2155-6-20**] Topotecan with further dose reduction, Neupogen day 2,3,4 [**2155-6-27**] Topotecan [**2155-7-14**]- CT abdomen and pelvis w/o contrast New extra-abdominal metastases noted along the partly visualized right lower chest wall [**2155-7-17**]- RUQ u/s with multiple liver metastasis no portal vein thrombosis   Social History: Married, husband is very supportive.
Physical Exam: Admission physical exam: Vitals: T:99.0 BP:105/60 P:120 R:12 18 O2:96% 2L NC General: Alert, oriented X 3, no acute distress HEENT: Sclera anicteric, dry mucous membranes, oropharynx clear, EOMI, PERRL Neck: supple, JVP not elevated, no LAD CV: Regular rate and rhythm, normal S1 + S2, no murmurs, rubs, gallops Lungs: Clear to auscultation bilaterally with decreased breath sounds toward the bases, no wheezes, rales, ronchi Abdomen: soft, non-tender, distended, bowel sounds present, no organomegaly .
Pertinent Results: ADMISSION LABS: [**2155-7-19**] 08:00PM BLOOD WBC-10.3# RBC-3.80* Hgb-12.0 Hct-35.9* MCV-95 MCH-31.7 MCHC-33.5 RDW-17.8* Plt Ct-287 [**2155-7-19**] 08:00PM BLOOD Neuts-91* Bands-0 Lymphs-0 Monos-9 Eos-0 Baso-0 Atyps-0 Metas-0 Myelos-0 [**2155-7-19**] 08:00PM BLOOD Hypochr-NORMAL Anisocy-1+ Poiklo-OCCASIONAL Macrocy-1+ Microcy-NORMAL Polychr-NORMAL Burr-OCCASIONAL [**2155-7-19**] 08:00PM BLOOD PT-13.7* PTT-23.7* INR(PT)-1.3* [**2155-7-19**] 08:00PM BLOOD Glucose-110* UreaN-24* Creat-2.0* Na-130* K-4.4 Cl-100 HCO3-19* AnGap-15 [**2155-7-19**] 08:00PM BLOOD ALT-21 AST-44* AlkPhos-222* TotBili-0.3 [**2155-7-19**] 08:00PM BLOOD cTropnT-<0.01 [**2155-7-19**] 08:00PM BLOOD Albumin-1.9* [**2155-7-20**] 04:28AM BLOOD Calcium-7.2* Phos-2.9 Mg-1.5* [**2155-7-19**] 08:00PM BLOOD Osmolal-268* [**2155-7-19**] 08:00PM BLOOD TSH-13* [**2155-7-19**] 08:00PM BLOOD ASA-NEG Ethanol-NEG Acetmnp-NEG Bnzodzp-NEG Barbitr-NEG Tricycl-NEG [**2155-7-19**] 07:47PM BLOOD Glucose-89 Lactate-4.4* Na-129* K-4.2 Cl-99 calHCO3-16* [**2155-7-20**] 12:21AM BLOOD Type-[**Last Name (un) **] pH-7.36 [**2155-7-20**] 12:21AM BLOOD Lactate-1.8 calHCO3-21 [**2155-7-19**] 07:47PM BLOOD Hgb-16.0 calcHCT-48  IMAGING: CXR [**7-19**]: Mild pulmonary edema and small left pleural effusion.
CT Chest [**2155-7-20**]: IMPRESSION: 1.
Echo [**2155-7-21**] The left atrium is normal in size.
Left ventricular wall thickness, cavity size, and global systolic function are normal (LVEF>55%).
There are no echocardiographic signs of tamponade.
Compared with the prior study (images reviewed) of [**2154-8-26**], no major change.
Renal ultrasound [**2155-7-21**] 1.
[**2155-7-22**] 05:24AM BLOOD Glucose-62* UreaN-24* Creat-2.1* Na-127* K-3.4 Cl-97 HCO3-19* AnGap-14 [**2155-7-22**] 05:24AM BLOOD ALT-18 AST-36 LD(LDH)-684* AlkPhos-236* TotBili-0.4 [**2155-7-22**] 05:24AM BLOOD Calcium-7.4* Phos-3.2 Mg-2.1  Brief Hospital Course: 64 y.o female with primary peritoneal carcinoma last round of Topotecan ending [**2155-7-1**], lung metastases, and recent right humerus fracture with 2 recent admissions for cellulitis/dehydration ([**Date range (1) 62150**]/[**2154**]) presenting with hypotension and mild dyspnea.
Systolic blood pressure stable at approx 100 on admission.
Obtained blood, peritoneal, and urine cultures which showed no growth.
Anion gap only 10 but albumin is 2.0 and there elevated anion gap acidosis.
Obtained TTE for full eval of cardiac function in setting of new effusion and low voltage EKG (new finding this admission).
TTE showed normal EF, trivial pericardial effusion, mitral and tricuspid regurgitation and mild pulmonary hypertension.
Also obtained CT chest non-con to eval new pleural effusion in setting of malignancy.
CT chest showed increased lymphadenopathy concerning for cancer progression, enlarging pleural effusions and possible pathologic fracture of right humerus.
Was 2.0 on admission.
Urine lytes c/w prerenal.
Worsened to 1.9-2.1 and urine output dropped significantly.
HYDROmorphone (Dilaudid) 2-4 mg PO Q4H:PRN pain 9.
